Gain Therapeutics GANX
NASDAQ GANX
$1.19 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Tax Provisions (2020 - 2026)

Updated

Gain Therapeutics (GANX) posted Tax Provisions of $104,070 for Q2 2026, down 26.3% from $141,205 a year earlier and down 43.2% from the prior quarter.

Analysis

Gain Therapeutics (GANX) Tax Provisions (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Tax Provisions at Gain Therapeutics was $906,540, up 19.6% year-over-year; for FY2025, it came in at $861,118, up 60.4% from FY2024.

  • Annual Tax Provisions shows a five-year compound annual growth rate of 175.9% (FY2020 to FY2025).
  • In prior years, Gain Therapeutics' Tax Provisions was $536,815 in FY2024 (+577.2%), $79,275 in FY2023 (-14.7%), $92,976 in FY2022 and $4,008 in FY2021 (-25.6%).
  • Quarterly Tax Provisions has run from a low of -$8,244 in Q4 2021 to a high of $549,288 in Q3 2025 over five years.
  • On a year-over-year basis, Tax Provisions increased in two of the last five quarters, with growth averaging 65.7%.
  • The strongest year-over-year quarter for Tax Provisions in the past five years was Q1 2023, with growth of 897.5%; the weakest was Q2 2024, with a decline of 95.5%.
  • According to Business Quant data, Tax Provisions for the three prior quarters was $183,066 (Q1 2026), $70,116 (Q4 2025) and $549,288 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.15 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.21 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 662.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 654.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 291.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 393.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 242.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -407.00 Mn
10 Gain Therapeutics 51.03 Mn -8.26 Mn - 104,070.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 104,070.00
Mar 31, 2026 183,066.00
Dec 31, 2025 70,116.00
Sep 30, 2025 549,288.00
Jun 30, 2025 141,205.00
Mar 31, 2025 101,000.00
Dec 31, 2024 504,738.00
Sep 30, 2024 11,000.00
Jun 30, 2024 1,209.00
Mar 31, 2024 19,874.00
Dec 31, 2023 14,502.00
Sep 30, 2023 21,456.00
Jun 30, 2023 26,589.00
Mar 31, 2023 16,728.00
Dec 31, 2022 78,105.00
Sep 30, 2022 4,048.00
Jun 30, 2022 9,146.00
Mar 31, 2022 1,677.00
Dec 31, 2021 -8,244.00
Sep 30, 2021 5,114.00
API Access

Gain Therapeutics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=GANX&period=max&api_key=YOUR_API_KEY